Sign in to continue:

Friday, July 24th, 2026

Peoples Financial Corp (PFBX) Reports Lower Q2 2026 Earnings Amid Decreased Net Interest Income, Maintains Strong Capital and Asset Quality

Peoples Financial Corporation Reports Lower Q2 2026 Earnings; Highlights Asset Quality, Liquidity, and Shareholder Equity

Key Highlights from Q2 2026 Financial Results

  • Q2 2026 Net Income Declines: Net income for the second quarter ended June 30, 2026, decreased to \$897,000, down \$345,000 from \$1,242,000 in the same quarter of 2025. Earnings per weighted average common share fell to \$0.19 from \$0.27 year over year. The decline was mainly due to a decrease in net interest income and a slight increase in interest expense.
  • Net Interest Income Slides: Net interest income dropped \$553,000 to \$4,919,000 in Q2 2026, compared to \$5,472,000 in Q2 2025. This was driven by a \$527,000 decrease in total interest income, primarily due to lower returns on securities and overnight federal funds, while total interest expense modestly increased by \$26,000 due to higher rates paid on borrowings.
  • Non-Interest Income & Expenses: Non-interest income increased to \$1,887,000 (from \$1,777,000), while non-interest expenses were relatively flat at \$5,798,000 (vs. \$5,762,000 a year ago).
  • First Half 2026 Performance: For the six months ended June 30, 2026, net income was \$2,343,000, down from \$2,552,000 in the prior year, with EPS at \$0.51 (down from \$0.55). The drop in income tax expense (\$519,000 vs \$620,000) reflects lower pre-tax earnings.
  • Returns and Efficiency: Return on average assets for Q2 2026 was 0.63% (slightly down from 0.64%), and return on average equity fell to 4.67% from 5.52%. The efficiency ratio worsened to 80% from 78%, indicating higher operating costs relative to income.

Asset Quality & Shareholder Equity Developments

  • Strong Asset Quality Maintained: The allowance for credit losses on loans was steady at \$3,100,000 (1.12% of loans), and nonaccrual loans decreased to \$486,000 from \$600,000. There were no loans past due 90 days or more that were still accruing at quarter end.
  • Shareholder Equity Increases: Total shareholders’ equity rose by \$1,043,000 to \$101,710,000 since December 31, 2025. This was mainly the result of six-month earnings of \$2,343,000, offset by dividends of \$88,000 and a \$469,000 increase in unrealized losses on available-for-sale securities due to higher market interest rates. Book value per share grew to \$22.03 from \$20.90.
  • Impact of Unrealized Losses: Unrealized losses on the available-for-sale securities portfolio are now \$29,398,000, up from \$28,929,000 at the prior year-end, reflecting rising interest rates. The company emphasized these losses are not due to credit deterioration, and there is no plan to realize them in net income in the near future due to strong liquidity and capital positions.
  • Leverage Ratio Remains Robust: The leverage ratio was a strong 15.22% as of June 30, 2026, unaffected by unrealized securities losses, owing to a regulatory opt-out election.

Liquidity and Balance Sheet Position

  • Deposits Increase: Total deposits reached \$609,777,000 at the end of Q2, up \$5,348,000 from December 31, 2025, largely due to inflows from public fund tax deposits. Most deposits are fully FDIC-insured, supporting the bank’s liquidity position.
  • Asset Growth: Total assets grew to \$771,025,000 (from \$761,340,000 in Q2 2025), while loans, net, increased to \$274,062,000 (from \$245,332,000).
  • Securities Portfolio: The securities portfolio declined to \$414,407,000 from \$437,829,000 year over year, reflecting changes in investment allocation and market values.

Outlook and Management Commentary

The company’s leadership reiterated its commitment to credit quality and close monitoring of economic and interest rate trends. They highlighted strong capital and liquidity positions, ongoing risk assessments, and a cautious but positive approach to asset management in a changing rate environment.

Shareholder and Market-Sensitive Information

  • Persistently High Unrealized Losses on Securities: The continued rise in unrealized losses due to higher interest rates could be a concern for some investors, though management stresses these are not credit-related and unlikely to be realized in the near term.
  • Lower Earnings and Deteriorating Efficiency Ratio: The year-over-year decline in profitability and higher efficiency ratio may affect investor sentiment, particularly if these trends persist.
  • Book Value Growth: Book value per share increased, which is positive for long-term shareholders, reflecting the company’s ability to generate and retain capital despite headwinds.
  • Strong Capital Ratios: The solid leverage ratio and well-capitalized status support the bank’s resilience and capacity for future growth or shareholder returns.

Company Profile

Founded in 1896, The Peoples Bank operates 18 branches across the Mississippi Gulf Coast and offers a full range of retail, commercial, and trust services. Common stock trades on the OTCQX Best Market under the symbol PFBX.

Forward-Looking Statements

The company cautions investors that forward-looking statements in this release are subject to risks and uncertainties, including interest rate changes, economic trends, and regulatory factors, which may cause actual results to differ materially from current expectations.


Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation. Investors should conduct their own due diligence and consult their financial advisor before making investment decisions. All statements are based on information available as of the date of the news release and are subject to change without notice.

View PEOPLES FINANCIAL CORP /MS/ Historical chart here



Midera Food Processing Secures $1 Billion Credit Facility Ahead of Middleby Spin-Off Completion

Middleby Announces \$1 Billion Credit Agreement for Midera F...

Carlyle Group Inc. 2025 Annual 10-K Report: Business Segments, Investments, and Financial Disclosures

Key Highlights from the 2025 10-K Filing Company Structur...

Cellectar Biosciences, Inc. Files Form 8-K: Updated Stock Incentive Plan and Corporate Details for 2026

Cellectar Biosciences, Inc. Announces Key Developments from ...